Breast cancer
Results
Phase 2
This trial looked at either ixabepilone with bevacizumab (Avastin) or paclitaxel (Taxol) with bevacizumab for breast cancer that has come back after treatment.
Recruitment start: 1 March 2007
Recruitment end: 7 March 2008
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr. Mark Verrill
Bristol-Myers Squibb
Experimental Cancer Medicine Centre (ECMC)
Last reviewed: 6 November 2013
CRUK internal database number: 894
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
